| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Gaston TR, Rasmussen GT |
Identification of 3,4 methylenedioxymethamphetamine |
Bureau of Narcotics ... |
1972 |
| Masoud A N |
Systematic Identification of Drugs of Abuse I: Spot Tests |
J.Pharm.Sci. |
1975 |
| Twente RT,Theeuwen ABE,Ve... |
Enige ervaringen met een gaschromatografische methode voor kwalitatief... |
Pharm.Weekbl. |
1975 |
| Pryor GT, Husain S, Mitom... |
Acute and Subacute Interactions Between delta-9-Tetrahydrocannabinol a... |
Ann.N.Y.Acad.Sci. |
1976 |
| Riedlinger JE |
The scheduling of MDMA: a pharmacist's perspective |
J Psychoactive Drugs |
1985 |
| Glennon RA, Yousif M, Nai... |
Methcathinone: a new and potent amphetamine-like agent |
Pharmacol Biochem Be... |
1987 |
| Callahan PM, Appel JB |
Differences in the stimulus properties of 3,4-methylenedioxyamphetamin... |
J Pharmacol Exp Ther |
1988 |
| Schechter MD |
Advantages and disadvantages of a rapid method to train drug discrimin... |
Pharmacol Biochem Be... |
1988 |
| Krystal JH, Price LH, Ops... |
Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood ... |
Am J Drug Alcohol Ab... |
1992 |
| Hermle L, Spitzer M, Borc... |
Psychological effects of MDE in normal subjects. Are entactogens a new... |
Neuropsychopharmacol... |
1993 |
| Hermle L, Spitzer M, Borc... |
Psychological effects of MDE in normal subjects. Are entactogens a new... |
Neuropsychopharmacol... |
1993 |
| Robinson TE, Castaneda E,... |
Effects of cortical serotonin depletion induced by 3,4-methylenedioxym... |
Neuropsychopharmacol... |
1993 |
| Marona-Lewicka D, Nichols... |
Behavioral effects of the highly selective serotonin releasing agent 5... |
Eur J Pharmacol |
1994 |
| Kintz P, Tracqui A, Mangi... |
Sweat testing in opioid users with a sweat patch |
J Anal Toxicol |
1996 |
| Vorhees CV |
Methods for detecting long-term CNS dysfunction after prenatal exposur... |
Drug Chem Toxicol |
1997 |
| Schwartz RH, Miller NS |
MDMA (ecstasy) and the rave: a review |
Pediatrics |
1997 |
| Baker LE, Taylor MM |
Assessment of the MDA and MDMA optical isomers in a stimulant-hallucin... |
Pharmacol Biochem Be... |
1997 |
| Glennon RA, Young R, Duka... |
Initial characterization of PMMA as a discriminative stimulus |
Pharmacol Biochem Be... |
1997 |
| Schechter MD |
Discrete versus cumulative dosing in dose-response discrimination stud... |
Eur J Pharmacol |
1997 |
| Tagliaro F, Manetto G, Be... |
Simultaneous chiral separation of 3,4-methylenedioxymethamphet- amine,... |
Electrophoresis |
1998 |
| Bolla KI, McCann UD, Rica... |
Memory impairment in abstinent MDMA ('Ecstasy') users |
Neurology |
1998 |
| Morgan MJ |
Recreational use of 'ecstasy' (MDMA) is associated with elevated impul... |
Neuropsychopharmacol... |
1998 |
| Obradovic T, Imel KM, Whi... |
Repeated exposure to methylenedioxymethamphetamine (MDMA) alters nucle... |
Brain Res |
1998 |
| Obradovic T, Imel KM, Whi... |
Repeated exposure to methylenedioxymethamphetamine (MDMA) alters nucle... |
Brain Res |
1998 |
| Bhattacharya SK, Bhattach... |
Anxiogenic activity of methylenedioxymethamphetamine (Ecstasy): an exp... |
Biogenic Amines |
1998 |
| Virden TB, Baker LE |
Disruption of the discriminative stimulus effects of S(+)-3,4-methylen... |
Behavioural Pharmaco... |
1999 |
| Dafters RI, Duffy F, O'Do... |
Level of use of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) in... |
Psychopharmacology (... |
1999 |
| Schirren CA, Berghaus TM,... |
Thrombotic thrombocytopenic purpura after Ecstasy-induced acute liver ... |
Ann Intern Med |
1999 |
| Tagliaro F, De Battisti Z... |
High sensitivity simultaneous determination in hair of the major const... |
J Chromatogr B Biome... |
1999 |
| Gouzoulis-Mayfrank E, Dau... |
Impaired cognitive performance in drug free users of recreational ecst... |
J Neurol Neurosurg P... |
2000 |
| Erdtmann-Vourliotis M, Ma... |
Prior experience of morphine application alters the c-fos response to ... |
Brain Res Mol Brain ... |
2000 |
| Morley KC, McGregor IS |
(+/-)-3,4-Methylenedioxymethamphetamine (MDMA, 'Ecstasy') increases so... |
Eur J Pharmacol |
2000 |
| Anderson C |
Water intake probed in death |
Boulder Daily Camera |
2001 |
| Bhattachary S, Powell JH |
Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or 'ecsta... |
Psychol Med |
2001 |
| Croft RC, Macay AJ, Mills... |
The relative contributions of ecstasy and cannabis to cognitive impair... |
Psychopharmacology (... |
2001 |
| Taffe MA, Weed MR, Davis ... |
Functional Consequences of Repeated (+/-)3,4-Methylenedioxymethampheta... |
Neuropsychopharmacol... |
2001 |
| Zakzanis K, Young DA |
Executive function in abstinent MDMA ('ecstasy') users |
Medical Science Moni... |
2001 |
| Heffernan TM, Jarvis H, R... |
Prospective memory, everyday cognitive failure and central executive f... |
Hum Psychopharm Clin... |
2001 |
| Morley KC, Gallate JE, Hu... |
Increased anxiety and impaired memory in rats 3 months after administr... |
Eur J Pharmacol |
2001 |
| Logan BK, Couper FJ |
3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) and driving impairme... |
J Forensic Sci |
2001 |
| Hayner, GN |
MDMA misrepresentation: An unresolved problem for ecstasy users |
J Psychoactive Drugs |
2002 |
| Heffernan TM, Ling J, Sch... |
Subjective ratings of prospective memory deficits in MDMA (\'ecstasy\'... |
Hum Psychopharmacol |
2002 |
| Crouch DJ, Hersch RK, Coo... |
A field evaluation of five on-site drug-testing devices. |
J Anal Toxicol |
2002 |
| Crouch DJ, Hersch RK, Coo... |
A field evaluation of five on-site drug-testing devices |
J Anal Toxicol |
2002 |
| Taffe MA, Davis SA, Yuan ... |
Cognitive performance of MDMA-treated rhesus monkeys: sensitivity to s... |
Neuropsychopharmacol... |
2002 |
| Timar J, Gyarmati S, Szab... |
Behavioural changes in rats treated with a neurotoxic dose regimen of ... |
Behav Pharmacol |
2003 |
| McGregor IS, Clemens KJ, ... |
Increased Anxiety 3 Months after Brief Exposure to MDMA ('Ecstasy') in... |
Neuropsychopharmacol... |
2003 |
| Gouzoulis-Mayfrank E, Thi... |
Memory impairment suggests hippocampal dysfunction in abstinent ecstas... |
Prog Neuropsychophar... |
2003 |
| Gerra G, Bassignana S, Za... |
Hypothalamic-pituitary-adrenal axis responses to stress in subjects wi... |
Psychiatry Res |
2003 |
| Jovanovski D, Zakzanis KK |
Donepezil in a chronic drug user--a potential treatment? |
Hum Psychopharmacol |
2003 |
| Back-Madruga C, Boone KB,... |
Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA ... |
Clin Neuropsychol |
2003 |
| Jacobsen LK, Mencl WE, Pu... |
Preliminary evidence of hippocampal dysfunction in adolescent MDMA ('e... |
Psychopharmacology (... |
2003 |
| Wang GJ, Volkow ND, Chang... |
Partial recovery of brain metabolism in methamphetamine abusers after ... |
Am J Psychiatry |
2004 |
| Ho YJ, Pawlak CR, Guo L, ... |
Acute and long-term consequences of single MDMA administration in rela... |
Behav Brain Res |
2004 |
| Daniela E, Brennan K, Git... |
Effect of SCH 23390 on (+/-)-3,4-methylenedioxymethamphetamine hyperac... |
Pharmacol Biochem Be... |
2004 |
| McCardle K, Luebbers S, C... |
Chronic MDMA (ecstasy) use, cognition and mood |
Psychopharmacology (... |
2004 |
| Khorana N, Pullagurla MR,... |
Comparison of the discriminative stimulus effects of 3,4-methylenediox... |
Drug Alcohol Depend |
2004 |
| Halpern JH, Pope HG Jr, S... |
Residual neuropsychological effects of illicit 3,4-methylenedioxymetha... |
Drug Alcohol Depend |
2004 |
| Ramaekers JG, Kuypers KP |
Acute Effects of 3,4-Methylenedioxymethamphetamine (MDMA) on Behaviora... |
Neuropsychopharmacol... |
2005 |
| Kuypers KP, Ramaekers JG |
Transient memory impairment after acute dose of 75mg 3.4-Methylene-dio... |
J Psychopharmacol |
2005 |
| Hayase T, Yamamoto Y, Yam... |
Behavioral effects of ketamine and toxic interactions with psychostimu... |
BMC Neurosci |
2006 |
| Williams MT, Herring NR, ... |
Alterations in Body Temperature, Corticosterone, and Behavior Followin... |
Neuropsychopharmacol... |
2006 |
| Schilt T, de Win MM, Koet... |
Cognition in novice ecstasy users with minimal exposure to other drugs... |
Arch Gen Psychiatry |
2007 |
| Carson DS, Cornish JL, Gu... |
Oxytocin decreases methamphetamine self-administration, methamphetamin... |
Neuropharmacology |
2009 |
| Kish SJ, Lerch J, Furukaw... |
Decreased cerebral cortical serotonin transporter binding in ecstasy u... |
Brain |
2010 |
| den Hollander B, Schouw M... |
Preliminary evidence of hippocampal damage in chronic users of ecstasy |
J Neurol Neurosurg P... |
2011 |
| Halpern JH, Sherwood AR, ... |
Reply to Parrott (2011), Fisk et al (2011) and Rodgers et al (2011) |
Addiction |
2011 |
| Venkatratnam A, Lents NH |
Zinc reduces the detection of cocaine, methamphetamine, and THC by ELI... |
J Anal Toxicol |
2011 |
| Pálenícek T, Lhotková E, ... |
Emerging toxicity of 5,6-methylenedioxy-2-aminoindane (MDAI): Pharmaco... |
Prog Neuropsychophar... |
2016 |
